The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial
EuroIntervention 2011;6:687-694.
Marcus Wiemer1, MD; Andreas König2, MD; Johannes Rieber2, MD; Hae-Young Sohn2, MD; Marcus Leibig2, MD; Karl Theisen2, MD; Volker Klauss2, MD; Christoph Langer1, MD; Oliver Lindner3, MD; Dieter Horstkotte1, MD, FESC, FACCP; Thomas M. Schiele2*, MD, FESC, FSCAI
1. Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany; 2. Cardiology Division, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany; 3. Department of Nuclear Medicine, Heart and Diabetes
Aims: Recent trials with different designs indicated that drug-eluting stents may be superior to vascular brachytherapy (VBT) for the treatment of in-stent restenosis (ISR). We performed a